SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-055069
Filing Date
2005-03-18
Accepted
2005-03-18 14:08:58
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 921980
2 DESCRIPTION OF OUTSIDE DIRECTOR COMPENSATION PROGRAM dex1012.htm EX-10.12 5198
3 DESCRIPTION OF EXECUTIVE OFFICER ANNUAL INCENTIVE CASH COMPENSATION PROGRAM dex1024.htm EX-10.24 5648
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1347
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8412
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8426
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 5131
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 5306
9 GRAPHIC g3277832778-10k_091.jpg GRAPHIC 37402
10 GRAPHIC g3277832778-10k_152.jpg GRAPHIC 35124
  Complete submission text file 0001193125-05-055069.txt   1036748
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 05691258
SIC: 2834 Pharmaceutical Preparations